Migraine headache management and prevention
Pro Research Analysisby 
Searched over 200M research papers
Migraine Headache Management: Acute and Preventive Strategies
Migraine is a common and disabling neurological disorder that requires a comprehensive management plan, including both acute and preventive strategies to reduce attack frequency, severity, and impact on daily life Ha2019Tzankova2023Lipton2015.
Acute Migraine Management: Immediate Relief
For acute migraine attacks, patients are typically treated with simple analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), or specific agents like triptans and ergot derivatives to relieve pain and restore function Goadsby2010Diener2015. Newer acute treatments targeting calcitonin gene-related peptide (CGRP) and serotonin (5-HT1F) receptors are also emerging as effective options .
Preventive Migraine Therapy: Who Needs It?
Preventive therapy is recommended for patients who experience frequent migraines (typically four or more headache days per month), have debilitating attacks, overuse acute medications, or have special types of migraine such as hemiplegic migraine or migraine with brainstem aura Ha2019Tzankova2023Silberstein2002+1 MORE. Preventive treatment aims to reduce the frequency, severity, and duration of attacks, improve quality of life, and prevent progression to chronic migraine Ha2019Tzankova2023Lipton2015.
Pharmacologic Prevention of Migraine
First-Line and Second-Line Medications
First-line preventive medications with strong evidence for effectiveness include:
- Divalproex
- Topiramate
- Metoprolol
- Propranolol
- Timolol Ha2019Tzankova2023Silberstein2002
Second-line options, which are probably effective, include:
- Amitriptyline
- Venlafaxine
- Atenolol
- Nadolol Ha2019Silberstein2002
Other medications such as gabapentin, SSRIs, calcium channel blockers, and some antihypertensives have limited or lower evidence for efficacy Ha2019Silberstein2002.
Newer Therapies
Recent advances include CGRP pathway inhibitors and onabotulinumtoxinA, which have shown high efficacy and good tolerability, especially for chronic migraine Diener2015Barad2021Sacco2025. OnabotulinumtoxinA is strongly recommended for chronic migraine prevention, while its use for episodic migraine is less supported . CGRP monoclonal antibodies represent a promising new class for both acute and preventive treatment Diener2015Sacco2025.
Non-Pharmacologic and Complementary Approaches
Lifestyle and Behavioral Interventions
Identifying and managing migraine triggers—such as environmental factors, sleep changes, diet, stress, and hormonal fluctuations—is crucial Ha2019Haghdoost2022. Behavioral therapies, including relaxation training, cognitive-behavioral therapy, and biofeedback, have strong evidence for reducing migraine frequency and improving patient outcomes Ha2019Haghdoost2022Silberstein2003.
Dietary Supplements and Alternative Therapies
Supplements like magnesium, riboflavin, coenzyme Q10, and herbal remedies such as petasites and feverfew are probably effective for some patients Ha2019Haghdoost2022. Acupuncture and neuromodulation techniques are also being explored as adjunctive or alternative preventive options Haghdoost2022Goadsby2010Diener2015.
Interventional and Device-Based Strategies
For patients with chronic migraine who do not respond to medications, interventional procedures such as occipital nerve blocks, sphenopalatine ganglion blocks, and implantable stimulation devices may be considered, though evidence varies and recommendations are generally weak . Neuromodulation approaches, both invasive and non-invasive, are under active investigation Goadsby2010Diener2015Barad2021.
Setting Higher Standards in Migraine Prevention
Recent expert consensus emphasizes the need to aim for ambitious treatment goals, such as complete migraine freedom or very low numbers of migraine days, rather than just a 50% reduction in frequency . This approach focuses on minimizing the residual burden and improving overall quality of life for patients .
Conclusion
Effective migraine management combines acute and preventive strategies tailored to individual needs. Pharmacologic options, including both established and newer agents, should be selected based on efficacy, safety, and patient comorbidities. Non-pharmacologic and complementary therapies play a vital role, especially when combined with medications. Ongoing research and higher standards in care are driving improvements in outcomes and quality of life for people living with migraine Ha2019Tzankova2023Haghdoost2022+7 MORE.
Sources and full results
Most relevant research papers on this topic